Startups
MRIguidance
Utrecht, Netherlands · New York, United States
MRIguidance is the Utrecht medical-imaging company legally identified as MRIguidance B.V. in FDA filings. MR physicist Peter Seevinck, image scientist Marijn van Stralen and entrepreneur Roel Raatgever founded it in 2016 as a University Medical Center Utrecht spinout. BoneMRI is its product and trademark, rather than a separately inferred company rename or acquisition. BoneMRI combines dedicated MRI acquisition and deep learning to generate three-dimensional CT-like bone images alongside aligned soft-tissue imaging. It supports radiology, musculoskeletal diagnostics and spine surgical planning and navigation without adding ionizing-radiation imaging. The software integrates with DICOM/PACS workflows through hospital or cloud processing. FDA record K233030 confirms a substantially-equivalent 510(k) clearance on 1 March 2024; scanner, anatomy and software-version indications apply. The February 2026 release describes spinal stitching, expanded scanner compatibility and IT improvements. Clinical superiority and market-leading statements remain attributed to the issuer. The current public directory names 20 management/staff members and three advisers. Guido Zijl succeeded Roel Kellenaers as CEO in February 2026; Seevinck is CSO and van Stralen CTO. Founder Raatgever died in late 2021, and the intervening leadership roles are recorded historically. Verified financing consists of a EUR1.5 million seed announced on 16 October 2018, a EUR750,000 bridge announced on 9 July 2020 involving an EIT Health co-investment grant in return for options and existing shareholders and a USD1.25 million Mammoth Scientific investment announced on 25 August 2021 through Mammoth Private Capital. EIT Health Bridgehead Global support in 2021 included a separate grant whose recipient-specific cash amount is undisclosed. Hospital customers, distribution partners, university collaborators and personal scientific grants are distinguished from company equity investments. A company-named NWO Take-off phase 2 development award dated 23 June 2017 is separately recorded with amount and instrument undisclosed; an award does not establish cash drawdown.
Founded 2016
Team
 Addie HarrisAdvisory Board Member |
Bas BuijtenhuisCustomer Service & Support Engineer |
Bram KooimanDeep Learning Engineer |
Dacina CrainicHead of Software Engineering |
Dionysios ZiogasCommercial Development Manager |
Elco OostProduct Integration Specialist |
 Eva HukshornCFO |
Florian CalvetDevSecOps Engineer |
 Guido ZijlCEO |
Harriet WeirClinical Commercial Specialist |
Hilde GeraedtsSenior Clinical Affairs Manager |
Huiqin ChenMedical Device Software Engineer |
Iulia LucaciuQA Officer |
Jasper van der GraafClinical Affairs Manager |
Kees van WijkSenior Software Architect |
 Kornelis PoelstraMedical Advisory Board Member |
Manuela EscobarMarketing & Communications Manager |
Marijn van StralenCo-Founder and CTO · Temporary CEO duties (historical: December 2021 announcement) |
 Peter SeevinckCo-Founder and CSO · Interim CEO (historical: early 2022–January 2025) |
 René CasteleinMedical Advisory Board Member |
Rick BergmansDeep Learning Lead |
 Roel KellenaersCEO (historical: January 2025–February 2026) · Chief Commercial Officer (historical: prior to January 2025 CEO appointment) |
 Roel RaatgeverCo-Founder and CEO (historical: 2016–late 2021; deceased) |
Stijn van WijngaardenDeep Learning Engineer |
Tijl van der VeldenClinical MRI Specialist |